Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Molina Healthcare, Inc. (NYSE:MOHGet Rating) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $357.25.

MOH has been the topic of several research analyst reports. Truist Financial dropped their target price on Molina Healthcare from $400.00 to $380.00 and set a “buy” rating on the stock in a research note on Friday, February 10th. Wells Fargo & Company reduced their target price on Molina Healthcare from $307.00 to $282.00 and set an “underweight” rating for the company in a report on Tuesday, March 21st. JPMorgan Chase & Co. dropped their price target on Molina Healthcare from $360.00 to $348.00 and set an “overweight” rating for the company in a research report on Thursday, February 23rd. Stephens reiterated an “equal weight” rating and issued a $375.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 9th. Finally, Credit Suisse Group upped their price target on Molina Healthcare from $347.00 to $350.00 in a research note on Friday, April 28th.

Molina Healthcare Price Performance

Shares of MOH stock opened at $299.53 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 1.47. Molina Healthcare has a fifty-two week low of $249.78 and a fifty-two week high of $374.00. The firm has a market cap of $17.46 billion, a P/E ratio of 20.40, a P/E/G ratio of 1.11 and a beta of 0.68. The business’s 50 day moving average price is $278.71 and its 200-day moving average price is $306.63.

Molina Healthcare (NYSE:MOHGet Rating) last released its quarterly earnings results on Wednesday, April 26th. The company reported $5.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.13 by $0.68. Molina Healthcare had a return on equity of 36.20% and a net margin of 2.64%. The business had revenue of $8.15 billion during the quarter, compared to analyst estimates of $8.31 billion. During the same quarter in the previous year, the company posted $4.90 earnings per share. Molina Healthcare’s revenue for the quarter was up 4.9% on a year-over-year basis. On average, equities research analysts anticipate that Molina Healthcare will post 20.25 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Daniel Cooperman sold 5,000 shares of the stock in a transaction that occurred on Friday, March 3rd. The shares were sold at an average price of $276.77, for a total value of $1,383,850.00. Following the completion of the transaction, the director now directly owns 4,944 shares in the company, valued at $1,368,350.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.10% of the stock is owned by insiders.

Institutional Investors Weigh In On Molina Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. JGP Global Gestao de Recursos Ltda. grew its holdings in shares of Molina Healthcare by 3.8% during the 3rd quarter. JGP Global Gestao de Recursos Ltda. now owns 847 shares of the company’s stock worth $279,000 after purchasing an additional 31 shares during the period. Captrust Financial Advisors raised its holdings in Molina Healthcare by 0.5% during the second quarter. Captrust Financial Advisors now owns 6,315 shares of the company’s stock worth $1,766,000 after purchasing an additional 33 shares during the last quarter. KBC Group NV raised its holdings in Molina Healthcare by 0.5% during the third quarter. KBC Group NV now owns 6,334 shares of the company’s stock worth $2,089,000 after purchasing an additional 33 shares during the last quarter. Lmcg Investments LLC raised its holdings in Molina Healthcare by 1.4% during the third quarter. Lmcg Investments LLC now owns 2,523 shares of the company’s stock worth $832,000 after purchasing an additional 35 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. grew its position in shares of Molina Healthcare by 4.3% in the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 921 shares of the company’s stock valued at $304,000 after purchasing an additional 38 shares during the period. Hedge funds and other institutional investors own 94.25% of the company’s stock.

Molina Healthcare Company Profile

(Get Rating)

Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Recommended Stories

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.